期刊文献+

白藜芦醇壳聚糖纳米粒的制备及理化性质 被引量:8

Preparation and Characterization of Resveratrol Chitosan Nanoparticles
原文传递
导出
摘要 目的建立白藜芦醇壳聚糖纳米粒的制备方法。方法以三聚磷酸钠作为离子聚合剂,在弱酸性条件下制备白藜芦醇壳聚糖纳米粒;考察pH值、壳聚糖与离子聚合剂浓度、白藜芦醇加入顺序、搅拌时间及探头超声等因素对纳米粒性质的影响,确定最佳制备工艺。结果在透射电子显微镜下,制备的白藜芦醇壳聚糖纳米粒呈球形;平均粒径为38nm,多分散指数为0.13;包封率与载药量分别为(61.6±2.3)%和(13.1±1.1)%;与白藜芦醇壳聚糖溶液相比,白藜芦醇壳聚糖纳米粒显示了明显的缓释效应。结论离子聚合法可用于小粒径壳聚糖纳米粒的制备。 OBJECTIVE To prepare resveratrol chitosan nanoparticles (RES-CS-NPs). METHODS Using sodium tripolyphosphate(TPP) as an ionic polymeric agent, RES-CS-NPs were formed in mild acid medium. The effects of pH, the concentration of CS and TPP, addition sequence, stirring time and treatment of probe ultrasound on the nanoparticles were investigated. RESULTS Under transmission electronic microscope, RES-CS-NPs were spherical. The mean diameter was 38 nm and polydispersity was 0.13. The encapsulation efficiency and drug loading were (61.6±2.3)% and (13.1±1.1)%, respectively. Compared with RES CS solution, RES-CS-NPs showed obvious sustained release property. CONCLUSION Ionic polymeric method is suitable for preparing the chitosan nanoparticles with small diameter.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第6期444-447,共4页 Chinese Pharmaceutical Journal
基金 成都大学校基金资助项目(070305)
关键词 白藜芦醇 壳聚糖 纳米粒 制备 resveratrol chitosan nanoparticles preparation
  • 相关文献

参考文献8

  • 1MEISHIANG J , LINING C , GEORGE O U , et al. Cancerchemopreventive activity of fresveratrol, a natural product derived from grapes[J]. Science, 1997, 275(5297): 218-220.
  • 2SILVIA B, LIVIA B, FRANCO P, et al. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism[J]. Eur Pharm, 2003, 465(1-2): 115-123.
  • 3TED W, TRAVIS J K, DONALD C B, et al. Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits[J]. LiJe Sci, 1996, 59(1): 15-21.
  • 4LU B, ZHANG Z R. Pharmacy (药剂学) [M]. Beijing: Chinese Medicinal Technology Press , 2003: 438.
  • 5VAN D L I, VERHOEF J C, BORCHARD G, et al. Chitosan for mucosal vaccination[J]. Adv Drug Deliv Rew, 2001, 52(2): 139-144.
  • 6曹翠珍,宗莉,陈立,张余云.三甲基化壳聚糖卵清蛋白纳米粒的制备[J].中国新药杂志,2007,16(1):61-65. 被引量:3
  • 7MIN L T, LAN Z T, RONG H C. Effects of removing small fragments with ultrafiltration treatment and ultrasonic conditions on the degradation kinetics of chitosan[J]. Polym Degrad Stab, 2004, 86(1): 25-32.
  • 8BERNARDO M V, BLANCO M D, SASTRE R L, et al, Sustained release of bupivacaine from devices based on chitosan [J]. Farmaco, 2003, 58(11): 1187-1191.

二级参考文献6

  • 1VAN DER LUBBEN IM,VERHOEF JC,VAN AELST AC,et al.Chitosan microparticles for oral vaccination:preparation,characterization and preliminary in vivo uptake studies in murine Peyer's patches[J].Biomaterials,2001,22 (7):687-694.
  • 2VAN DER LUBBEN IM,VERHOEF JC,BORCHARD G,et al.Chitosan for mucosal vaccination[J].Adv Drug Deliv Rew,2001,52(2):139-144.
  • 3MA Z,YEOH HH,LIM LY.Formulation pH modulates the interaction of insulin with chitosna nanoparticles[J].J Pharm Sci,2002,91 (6):1396-1404.
  • 4XU Y,DU Y.Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles[J].Int J Pharm,2003,250(1):215-226.
  • 5SNYMAN D,HAMMAN JH,KOTZE JS,et al.The relationship between the absolute molecular weight and the degree of quaternisation of N-trimethyl chitosan chloride[J].Carbohydr Polym,2002,50(2):145-150.
  • 6VAN DER MERWE SM,VERHOEF JC,VERHEIJDEN JHM,et al.Trimethylated chitosan as polumeric absorption enhancer for improved peroral delivery of peptide drugs[J].Eur J Pharm Biopharm,2004,58 (2):225-235.

共引文献2

同被引文献119

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部